mhurhangee/ep-ind-claims huggingface dataset:
An information processing device comprising: an operation unit configured to detect an input by user; a sensor configured to detect that the information processing device is worn on a part of a human body; a microphone configured to receive sound; a processing unit configured to process information; and a communication unit configured to communicate with another device, wherein the processing unit is configured to perform transmission of the sound received by the microphone to the another device in a case that the sensor detects that the information processing device is worn on a part of human body and the operation unit detects at least one input and the processing unit is configured to receive a voice instruction for the another device as the sound from the microphone. an operation unit configured to detect an input by user; a sensor configured to detect that the information processing device is worn on a part of a human body; a microphone configured to receive sound; a processing unit configured to process information; and a communication unit configured to communicate with another device, wherein the processing unit is configured to perform transmission of the sound received by the microphone to the another device in a case that the sensor detects that the information processing device is worn on a part of human body and the operation unit detects at least one input and the processing unit is configured to receive a voice instruction for the another device as the sound from the microphone.
A plurality of medical cap devices (500, 504) removably adhered to a substrate, each medical cap device (500, 504) comprises at least: a bottom end having a cavity; and a closed top end opposite the bottom end; wherein each medical cap device (500, 504) is removably adhered to the substrate by the top end, wherein the bottom end is covered by a removable protective film to thereby seal the cavity, and wherein the substrate is flexible and rollable. a bottom end having a cavity; and a closed top end opposite the bottom end; wherein each medical cap device (500, 504) is removably adhered to the substrate by the top end, wherein the bottom end is covered by a removable protective film to thereby seal the cavity, and wherein the substrate is flexible and rollable.
Canopy having at least two lateral beams (1, 2) on which a plurality of slats (10, 20, 30) are each mounted so as to be pivotable about an axis of rotation, wherein the axes of rotation of the slats (10, 20, 30) extend from one beam (1; 2) to the other beam (2; 1) and each have a longitudinal extent bounded by a first side and an opposite second side, the slats (10, 20, 30) being pivotable from a closed position, in which the slats (10, 20, 30) form a closed roof surface, into an, in particular arbitrary, open position, wherein the slats (10, 20, 30) are kinetically coupled to one another by means of at least one coupling rod, characterised in that at least one compression spring is arranged between a beam (1, 2) and the coupling rod and/or at least one slat (10, 20, 30) in such a way that a fixed end of the compression spring engages on the beam (1, 2), while a free end of the compression spring engages on the coupling rod and/or on the slat (10, 20, 30) and at all times exerts a compressive force on the coupling rod and/or on the slat (10, 20, 30) in the closing direction of the slats (10, 20, 30), the compression spring being arranged in such a way that a compressive force in the closing direction of the slats (10, 20, 30) is also exerted on the coupling rod in the closed position of the slats (10, 20, 30).
An iron-based alloy composition comprising boron: 1.6-2.4 wt.%; carbon: 2.2-3.0 wt.%; chromium (Cr): 3.5-5.0 wt.%; manganese (Mn): below 0.8 wt.%; molybdenum (Mo): 16.0-19.5 wt.%; nickel (Ni): 1.0-2.0 wt.%; silicon (Si): 0.2-2.0 wt.%; vanadium: 10.8-13.2 wt.%; and balanced with iron (Fe).
A process for producing particles of a substance comprising: • delivering a solution of the substance in a solvent through a conduit at a flow rate of at least 1 L/s in at least one bolus from a pressurisable injection chamber into a supercritical fluid disposed in a precipitation chamber, said supercritical fluid being a non-solvent for the substance and being miscible with the solvent, and • forming particles of the substance, said particles being distributed in a mixture of the solvent and the supercritical fluid, said process being conducted without the use of capillary nozzles or orifices to effect atomisation of the solution. • delivering a solution of the substance in a solvent through a conduit at a flow rate of at least 1 L/s in at least one bolus from a pressurisable injection chamber into a supercritical fluid disposed in a precipitation chamber, said supercritical fluid being a non-solvent for the substance and being miscible with the solvent, and • forming particles of the substance, said particles being distributed in a mixture of the solvent and the supercritical fluid,
Plastics laminate made of at least two poly (meth) acrylate layers and and of a layer located there between made of a thermoplastic polyurethane, characterized in that the thermoplastic polyurethane has from 30 to 60% by weight of hard segments and from 40 to 70% by weight of soft segments.
An endoscopic instrument having an elongate body with a distal end designed to be introduced into the body of the patient so as to come into proximity with an internal organ, the distal end carrying a tool for intervention on the internal organ, the endoscopic instrument having a foot (10, 110) rigidly connected to the distal end and designed to bear on the internal organ, and also controllable means of movement (13, 13', 113) for conferring movements on the tool, at least in directions transverse to a longitudinal axis of the distal end of the endoscopic instrument, when the foot is bearing against the internal organ, the endoscopic instrument being characterized in that the means of movement have at least one actuator (13, 13', 113, 213), which is coupled to the tool and which is arranged entirely within the foot.
Installation switch or installation button comprising a device base including an operating element, a rocker which acts on the operating element, a supporting ring, a covering frame and lighting system, wherein an optical waveguide is arranged on the rear side of the rocker, and wherein a lamp holder comprising a lamp is arranged in the device base, the light from the said lamp shining into a light inlet area of the optical waveguide, characterized in that the rocker has a light outlet opening on its side edge which faces only in the direction of the floor or only in the direction of the ceiling when the installation switch or installation button is mounted, which light outlet opening accommodates a light outlet area of the optical waveguide, so that the floor which is located beneath the mounted installation switch or installation button or the ceiling which is located above the mounted installation switch or installation button is illuminated and the main surface of the optical waveguide, with the exception of the light inlet area and the light outlet area, is provided with an opaque reflection layer.
Nucleic acid sequence comprising or coding in 5'→3' direction for i) - a coding region, encoding at least one peptide or protein; - at least one histone stem-loop, and - a poly sequence; or ii) - a coding region, encoding at least one peptide or protein; - a poly sequence, and - at least one histone stem-loop; wherein the at least one histone stem-loop in i) or ii) is selected from SEQ ID NO: 27 or SEQ ID NO: 42; and wherein said peptide or protein comprises a pathogenic antigen or a fragment thereof having a length of at least six amino acid residues and having the specific antigenic property of the full-length native peptide or protein, wherein the pathogenic antigen is associated with a bacterial infection, a viral infection, or a protozoan infection and wherein the pathogenic antigen is selected from a pathogenic antigen of a pathogen of the group consisting of • Respiratory syncytial virus, • Human immunodeficiency virus, • Herpes simplex virus, • Human Papillomavirus, • Human parainfluenza virus (HPIV), • Dengue virus, • Hepatitis B virus, • Influenza virus, • Yellow fever virus, • Rabies virus, • Plasmodium, • Cytomegalovirus, • Staphylococcus, • Mycobacterium tuberculosis, • Chlamydia trachomatis, • Rotavirus, • Human metapneumovirus (hMPV), • Crimean Congo Hemorrhagic Fever Virus (CCHFV), • Ebola virus, • Henipavirus, • Norovirus, • Lassa virus, • Coronavirus, • Rhinovirus, • Flavivirus, • Rift Valley Fever Virus, and • Hand, foot and mouth disease virus. i) - a coding region, encoding at least one peptide or protein; - at least one histone stem-loop, and - a poly sequence; or - a coding region, encoding at least one peptide or protein; - at least one histone stem-loop, and - a poly sequence; or ii) - a coding region, encoding at least one peptide or protein; - a poly sequence, and - at least one histone stem-loop; - a coding region, encoding at least one peptide or protein; - a poly sequence, and - at least one histone stem-loop; • Respiratory syncytial virus, • Human immunodeficiency virus, • Herpes simplex virus, • Human Papillomavirus, • Human parainfluenza virus (HPIV), • Dengue virus, • Hepatitis B virus, • Influenza virus, • Yellow fever virus, • Rabies virus, • Plasmodium, • Cytomegalovirus, • Staphylococcus, • Mycobacterium tuberculosis, • Chlamydia trachomatis, • Rotavirus, • Human metapneumovirus (hMPV), • Crimean Congo Hemorrhagic Fever Virus (CCHFV), • Ebola virus, • Henipavirus, • Norovirus, • Lassa virus, • Coronavirus, • Rhinovirus, • Flavivirus, • Rift Valley Fever Virus, and • Hand, foot and mouth disease virus.
A laminate for battery encasement comprising aluminum foil, an inner layer, and a resin film layer, in which the resin film layer consists of an aminated phenol polymer, an acrylic polymer, a phosphorus compound and a zirconium compound, and lies between the aluminum foil and the inner layer.
Air suspension system for a rail vehicle, having - at least two pneumatic springs, - a compressed air supply system for supplying the pneumatic springs with compressed air, - and at least one equalisation device for reducing a pressure difference between pneumatic springs, - wherein the equalisation device has at least one first control port (17a,17b) connected to at least one of the pneumatic springs and a second connected to at least one other pneumatic spring, - and switching means which can be switched by means of the pressure difference present at the two control ports and bring about a pressure equalisation between the first and second control port in at least one switching position, characterised in that - the equalisation device has at least one outflow (18a,18b) connected to the surroundings of the rail vehicle as a pressure sink and - the switching means connect the control port (17a,17b), to which a high pressure is applied, through to at least one outflow (18a,18b) in the event of a pressure equalisation by the equalisation device. - at least two pneumatic springs, - a compressed air supply system for supplying the pneumatic springs with compressed air, - and at least one equalisation device for reducing a pressure difference between pneumatic springs, - wherein the equalisation device has at least one first control port (17a,17b) connected to at least one of the pneumatic springs and a second connected to at least one other pneumatic spring, - and switching means which can be switched by means of the pressure difference present at the two control ports and bring about a pressure equalisation between the first and second control port in at least one switching position, characterised in that - the equalisation device has at least one outflow (18a,18b) connected to the surroundings of the rail vehicle as a pressure sink and - the switching means connect the control port (17a,17b), to which a high pressure is applied, through to at least one outflow (18a,18b) in the event of a pressure equalisation by the equalisation device.
A method of calibrating a measurement signal apparatus for use in a method of controlling a process for the manufacture of a multicomponent sheet material comprising a pre-impregnated fibre reinforced structure having a desired predetermined parameter comprising: a. Manufacturing a multicomponent sheet material applying an ultrasound signal to interact with the sheet material during its production, b. Detecting the measurement signal after interaction with the sheet material, c. Analysing one or more parameters of the sheet material by a water pickup method and d. Correlating the detected measurement signals with the results of the water pickup method thereby to calibrate the detected measurement signal results with the one or more parameters of the sheet material. a. Manufacturing a multicomponent sheet material applying an ultrasound signal to interact with the sheet material during its production, b. Detecting the measurement signal after interaction with the sheet material, c. Analysing one or more parameters of the sheet material by a water pickup method and d. Correlating the detected measurement signals with the results of the water pickup method thereby to calibrate the detected measurement signal results with the one or more parameters of the sheet material.
A temperature control system adapted to be applied to an apparatus for analyzing a sample using a pipette tip which is fitted on a pipette nozzle and aspirates or discharges liquid in a reaction container, the temperature control system comprising: a reaction container temperature control portion adapted to heat the reaction container; a pipette tip temperature control portion comprising a housing with an internal space, a heat source adapted to emit hot air in the internal space of the housing, and an opening portion in a part of the housing allowing upward and downward movement of the pipette; wherein, in use, the pipette tip temperature control portion is adapted to heat the internal space of the housing in a concentrated manner using the hot air emitted from the heat source, thereby heating at least a distal end portion of the pipette tip of the pipette nozzle located at a predetermined heating position inside the internal space of the housing and wherein the pipette tip temperature control portion is configured such that, in use, a distal end of the pipette tip is capable of arriving at the reaction container by lowering the pipette nozzle from the heating position through the opening portion,and such that, in use, at least the distal end of the pipette tip is located outside the housing if the pipette nozzle is lowered from the heating position through the opening portion of the housing. a reaction container temperature control portion adapted to heat the reaction container; a pipette tip temperature control portion comprising a housing with an internal space, a heat source adapted to emit hot air in the internal space of the housing, and an opening portion in a part of the housing allowing upward and downward movement of the pipette; wherein, in use, the pipette tip temperature control portion is adapted to heat the internal space of the housing in a concentrated manner using the hot air emitted from the heat source, thereby heating at least a distal end portion of the pipette tip of the pipette nozzle located at a predetermined heating position inside the internal space of the housing and wherein the pipette tip temperature control portion is configured such that, in use, a distal end of the pipette tip is capable of arriving at the reaction container by lowering the pipette nozzle from the heating position through the opening portion,and such that, in use, at least the distal end of the pipette tip is located outside the housing if the pipette nozzle is lowered from the heating position through the opening portion of the housing.
A pharmaceutical composition for use in the treatment of HIV-infection in solid dosage form, which contains at least one HIV protease inhibitor in therapeutically effective amount selected from the group of nelfinavir, saquinavir, tipranavir, darunavir, indinavir, atazanavir, ritonavir, lopinavir, palinavir, and fosamprenavir; and pharmaceutically acceptable excipients, characterized in that the composition comprises at least one water-soluble polymer in the amount from 0.4 to 49% w/w of the total dosage form and at least one pharmaceutically acceptable water-insoluble polymer in the amount from 0.39 to 28% w/w of the total finished dosage form as pharmaceutically acceptable excipient, as well as surfactants and fillers up to 100% of the total finished dosage form.
A method for providing a prognosis for a subject having suffered from a computed tomography -negative mild traumatic brain injury (mTBI), or for monitoring response to therapy in a subject having suffered from a computed tomography -negative mild traumatic brain injury (mTBI), said method comprising: analyzing a biological sample that has been obtained from said subject to determine the level of a biomarker associated with the presence of said mTBI, wherein said biomarker is a calpain-cleaved αII-spectrin N-terminal fragment (SNTF), and comparing said level of said biomarker to the level of a pre-determined standard, thereby providing said prognosis for, or monitoring a response to therapy, in said subject having suffered from said mTBI. analyzing a biological sample that has been obtained from said subject to determine the level of a biomarker associated with the presence of said mTBI, wherein said biomarker is a calpain-cleaved αII-spectrin N-terminal fragment (SNTF), and comparing said level of said biomarker to the level of a pre-determined standard, thereby providing said prognosis for, or monitoring a response to therapy, in said subject having suffered from said mTBI.
A multi-passage installation structure for pipe bundles, i.e. a multi-passage installation structure for service cables and/or pipes through a wall, comprising a mask, having a plate body provided with a plurality of through openings between two opposite faces (11, 12) of the plate body and associated to respective sleeves which project from the plate body and define, in use, respective passages for service cables; and a peripheral gasket arranged about the plate body along an outer peripheral edge of the plate body; characterized in that the gasket is housed in a seat formed along the peripheral edge and leans against a bottom surface, defined by a radially outer surface of the peripheral edge, and, laterally, against opposite lateral restraint elements, which project outwards from the peripheral edge on opposite sides of the bottom surface.
A method of diagnosing ovarian cancer comprising the steps of: (a) determining an expression profile of a predetermined set of miRNAs in a blood cellular fraction comprising erythrocytes, leukocytes, and thrombocytes from a patient; and (b) comparing said expression profile to a reference expression profile, wherein the comparison of said determined expression profile to said reference expression profile allows for the diagnosis of ovarian cancer, wherein the predetermined set of miRNAs comprises at least two miRNAs selected from Figures 2 or 14, or at least one set of miRNAs listed in Figure 15. (a) determining an expression profile of a predetermined set of miRNAs in a blood cellular fraction comprising erythrocytes, leukocytes, and thrombocytes from a patient; and (b) comparing said expression profile to a reference expression profile, wherein the comparison of said determined expression profile to said reference expression profile allows for the diagnosis of ovarian cancer,
A personal care article comprising: a.) a porous dissolvable solid substrate comprising: i. from 10% to 75% surfactant; ii. from 10% to 50% water-soluble polymer; iii. from 1% to 30% plasticizer; and b.) a surface resident coating comprising from 10% to 100% of one or more cyclodextrin perfume complexes; wherein the ratio of the cyclodextrin to perfume in the complex is from 100:1 to 1:1, and wherein the ratio of the porous dissolvable solid substrate to the surface resident coating is from 110:1 to 0.5:1. a.) a porous dissolvable solid substrate comprising: i. from 10% to 75% surfactant; ii. from 10% to 50% water-soluble polymer; iii. from 1% to 30% plasticizer; and i. from 10% to 75% surfactant; ii. from 10% to 50% water-soluble polymer; iii. from 1% to 30% plasticizer; and b.) a surface resident coating comprising from 10% to 100% of one or more cyclodextrin perfume complexes;
Heat exchanger, comprising a number of sheets (1, 4) stacked onto each other and extending mutually parallel, - wherein at least some of the number of sheets are provided over at least a part of their surface with profiles which form ducts extending between the sheets and wherein the ducts present on either side of a sheet extend parallel and wherein the profiles have upper and lower walls (6,7) extending parallel to the main plane of the sheets (1, 4); - wherein each of the sheets (1, 4) lies adjacent on one of its sides to ducts of a first type and lies adjacent on its other side to ducts of a second type; - wherein adjoining sheets (1, 4) stacked onto each other are mutually connected at their edges extending parallel to the ducts; - wherein all sheets are provided with a profile and the profile of each sheet extends over the whole surface of the heat exchanger; - wherein the average height of the ducts is greater than their average width, - wherein the sheets are stacked with the lower walls of an upper-lying sheet above the upper walls of the underlying sheet; wherein the profile arrangement in the sheets and forming the ducts has a form of a trapezium, repeating itself, characterized in that the sheets have a fold (9, 10) on both their upper and lower walls (6, 7) extending parallel to the main plane of the sheets (1, 4), wherein the folds in the upper walls extend in the same direction as the folds in the lower walls and wherein the fold of an upper wall of an underlying sheets fits into the fold of a lower wall of an upperlying sheet. - wherein at least some of the number of sheets are provided over at least a part of their surface with profiles which form ducts extending between the sheets and wherein the ducts present on either side of a sheet extend parallel and wherein the profiles have upper and lower walls (6,7) extending parallel to the main plane of the sheets (1, 4); - wherein each of the sheets (1, 4) lies adjacent on one of its sides to ducts of a first type and lies adjacent on its other side to ducts of a second type; - wherein adjoining sheets (1, 4) stacked onto each other are mutually connected at their edges extending parallel to the ducts; - wherein all sheets are provided with a profile and the profile of each sheet extends over the whole surface of the heat exchanger; - wherein the average height of the ducts is greater than their average width, - wherein the sheets are stacked with the lower walls of an upper-lying sheet above the upper walls of the underlying sheet;
A wet cleaning device, comprising: a mopping unit for wet cleaning a surface, and an arrangement for increasing a pressure of the mopping unit to the surface by means of suction, characterized in that the arrangement includes a hose at a side of the mopping unit, the hose having an opening for applying suction to the surface. a mopping unit for wet cleaning a surface, and an arrangement for increasing a pressure of the mopping unit to the surface by means of suction, characterized in that